Ballentine Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.52M | Buy |
|
|||||
|
2025
Q2 | $2.4M | Sell |
|
|||||
|
2025
Q1 | $2.62M | Buy |
|
|||||
|
2024
Q4 | $2.02M | Buy |
|
|||||
|
2024
Q3 | $1.67M | Buy |
|
|||||
|
2024
Q2 | $784K | Buy |
|
|||||
|
2024
Q1 | $809K | Sell |
|
|||||
|
2023
Q4 | $1.23M | Buy |
|
|||||
|
2023
Q3 | $707K | Buy |
|
|||||
|
2023
Q2 | $666K | Buy |
|
|||||
|
2023
Q1 | $595K | Buy |
|
|||||
|
2022
Q4 | $573K | Buy |
|
|||||
|
2022
Q3 | $357K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $248K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $215K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $375K | Sell |
|
|||||
|
2020
Q2 | $498K | Sell |
|
|||||
|
2020
Q1 | $490K | Buy |
|
|||||
|
2019
Q4 | $369K | Buy |
|
|||||
|
2019
Q3 | $347K | Buy |
|
|||||
|
2019
Q2 | $363K | Buy |
|
|||||
|
2019
Q1 | $323K | Buy |
|
|||||
|
2018
Q4 | $297K | Sell |
|
|||||
|
2018
Q3 | $430K | Sell |
|
|||||
|
2018
Q2 | $400K | Sell |
|
|||||
|
2018
Q1 | $442K | Sell |
|
|||||
|
2017
Q4 | $474K | Sell |
|
|||||
|
2017
Q3 | $656K | Sell |
|
|||||
|
2017
Q2 | $630K | Buy |
|
|||||
|
2017
Q1 | $355K | Sell |
|
|||||
|
2016
Q4 | $399K | Sell |
|
|||||
|
2016
Q3 | $472K | Sell |
|
|||||
|
2016
Q2 | $530K | Sell |
|
|||||
|
2016
Q1 | $609K | Sell |
|
|||||
|
2015
Q4 | $739K | Buy |
|
|||||
|
2015
Q3 | $671K | Buy |
|
|||||
|
2015
Q2 | $725K | Sell |
|
|||||
|
2015
Q1 | $609K | Sell |
|
|||||
|
2014
Q4 | $604K | Buy |
|
|||||
|
2014
Q3 | $663K | Buy |
|
|||||
|
2014
Q2 | $477K | Sell |
|
|||||
|
2014
Q1 | $418K | Buy |
|
|||||
|
2013
Q4 | $434K | Sell |
|
|||||
|
2013
Q3 | $391K | Buy |
|
|||||
|
2013
Q2 | $213K | Buy |
|